| Nome |
# |
|
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis, file e39773b2-1c08-35a3-e053-3a05fe0aac26
|
2.187
|
|
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE, file e39773b2-2fc0-35a3-e053-3a05fe0aac26
|
910
|
|
Caratterizzazione dell'effetto analgesico di un nuovo ligando del recettore I2 imidazolinico in un modello animale di dolore neuropatico indotto da bortezomib, file e39773b1-8b95-35a3-e053-3a05fe0aac26
|
699
|
|
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model, file e39773b2-1c52-35a3-e053-3a05fe0aac26
|
431
|
|
Granulocytes in actively induced Lewis rat EAE, file e39773b4-b98e-35a3-e053-3a05fe0aac26
|
430
|
|
MSCs effect on Dark Agouti rats affected by chronic EAE, file e39773b1-f4c1-35a3-e053-3a05fe0aac26
|
279
|
|
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis., file e39773b4-dab6-35a3-e053-3a05fe0aac26
|
221
|
|
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain, file e39773b2-0bd4-35a3-e053-3a05fe0aac26
|
169
|
|
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy, file e39773b7-237b-35a3-e053-3a05fe0aac26
|
164
|
|
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy, file e39773b2-1b32-35a3-e053-3a05fe0aac26
|
152
|
|
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy, file e39773b7-438e-35a3-e053-3a05fe0aac26
|
129
|
|
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy, file e39773b8-c109-35a3-e053-3a05fe0aac26
|
102
|
|
Reversal of bortezomib-induced neurotoxicity by suvecaltamide, a selective T-type ca-channel modulator, in preclinical models, file e39773b8-0628-35a3-e053-3a05fe0aac26
|
100
|
|
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity, file e39773b6-d43d-35a3-e053-3a05fe0aac26
|
97
|
|
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats, file e39773b7-32a4-35a3-e053-3a05fe0aac26
|
97
|
|
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer, file e39773b7-0ea5-35a3-e053-3a05fe0aac26
|
92
|
|
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats, file e39773b2-164e-35a3-e053-3a05fe0aac26
|
89
|
|
Neurotoxicity induced by cisplatin, taxol and bortezomib in immunocompetent cd1 mice and immunodeficient nude mice, file e39773b2-1acf-35a3-e053-3a05fe0aac26
|
79
|
|
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats, file e39773b6-b52b-35a3-e053-3a05fe0aac26
|
67
|
|
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights, file e39773b6-b1ab-35a3-e053-3a05fe0aac26
|
66
|
|
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity, file e39773b6-b81b-35a3-e053-3a05fe0aac26
|
64
|
|
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity, file e39773b6-f6cc-35a3-e053-3a05fe0aac26
|
63
|
|
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton, file e39773b7-a0af-35a3-e053-3a05fe0aac26
|
60
|
|
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect, file e39773b7-6a81-35a3-e053-3a05fe0aac26
|
59
|
|
Peripheral neuropathy induced by chronic administration of cisplatin, taxol and bortezomib in several murine models, file e39773b2-167c-35a3-e053-3a05fe0aac26
|
57
|
|
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification, file e39773b6-dab3-35a3-e053-3a05fe0aac26
|
57
|
|
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse, file e39773b2-1679-35a3-e053-3a05fe0aac26
|
53
|
|
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE, file e39773b7-0303-35a3-e053-3a05fe0aac26
|
51
|
|
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics, file e39773b9-4462-35a3-e053-3a05fe0aac26
|
50
|
|
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS, file e39773b2-196d-35a3-e053-3a05fe0aac26
|
48
|
|
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis, file e39773b2-1635-35a3-e053-3a05fe0aac26
|
44
|
|
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY, file e39773b2-1969-35a3-e053-3a05fe0aac26
|
42
|
|
Neurochemical characterization of bortezomib-induced peripheral neuropathy: expression of trpv1, cgrp and substance p in the rat drg and dorsal horn of spinal cord, file e39773b2-1b34-35a3-e053-3a05fe0aac26
|
40
|
|
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level, file e39773b2-13dd-35a3-e053-3a05fe0aac26
|
39
|
|
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS, file e39773b2-150a-35a3-e053-3a05fe0aac26
|
38
|
|
null, file e39773b2-1a5b-35a3-e053-3a05fe0aac26
|
36
|
|
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models, file e39773b2-1956-35a3-e053-3a05fe0aac26
|
35
|
|
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain, file e39773b2-0be4-35a3-e053-3a05fe0aac26
|
30
|
|
Transient receptor potential vanilloid type 1 (TRPV1) and neuropeptides in the dorsal root ganglia and spinal cord in a rat model of Bortezomib-induced neuropathy, file e39773b2-1d69-35a3-e053-3a05fe0aac26
|
27
|
|
CHARACTERIZATION OF BORTEZOMIB- INDUCED PERIPHERAL NEUROPATHY IN EXPERIMENTAL ANIMAL MODELS, file e39773b2-0c32-35a3-e053-3a05fe0aac26
|
26
|
|
null, file e39773b2-19fd-35a3-e053-3a05fe0aac26
|
26
|
|
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE, file e39773b7-8f17-35a3-e053-3a05fe0aac26
|
24
|
|
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity, file a532b52d-9098-4669-ae4a-87444f532efe
|
22
|
|
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?, file 9483fb75-5736-4668-a72b-e6605abc85bc
|
21
|
|
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics, file e39773b9-3c4d-35a3-e053-3a05fe0aac26
|
17
|
|
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing, file 45486cc9-830d-42fc-bc60-c746eea64a6c
|
15
|
|
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL, file e39773b2-1a10-35a3-e053-3a05fe0aac26
|
12
|
|
Ubiquitin Proteasome System and Microtubules Are Master Regulators of Central and Peripheral Nervous System Axon Degeneration, file 30a4a17f-8063-4dc2-8ea9-04ee220502ee
|
11
|
|
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS, file e39773b3-2844-35a3-e053-3a05fe0aac26
|
11
|
|
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity, file e42c0ca3-73cd-42c6-86c5-38199894ff13
|
10
|
|
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats, file cea6553f-71dd-4608-96fa-1c22547da1fa
|
9
|
|
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect, file e39773b7-9626-35a3-e053-3a05fe0aac26
|
9
|
|
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY, file e39773b2-1420-35a3-e053-3a05fe0aac26
|
8
|
|
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS, file e39773b2-1977-35a3-e053-3a05fe0aac26
|
8
|
|
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats, file e39773b7-8c00-35a3-e053-3a05fe0aac26
|
6
|
|
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model., file e39773b2-1a9d-35a3-e053-3a05fe0aac26
|
5
|
|
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats, file e39773b2-2f84-35a3-e053-3a05fe0aac26
|
3
|
|
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF DIFFERENT MOLECULAR MECHANISMS, file e39773b5-e1b1-35a3-e053-3a05fe0aac26
|
3
|
|
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models, file e39773b2-1803-35a3-e053-3a05fe0aac26
|
1
|
|
The part of the Complete Freund’s Adjuvant in actively induced Experimental Autoimmune Encephalomyelitis in Lewis rat., file e39773b2-2580-35a3-e053-3a05fe0aac26
|
1
|
|
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy, file e39773b8-47f0-35a3-e053-3a05fe0aac26
|
1
|
| Totale |
7.702 |
